Открыть Электронные книги
Категории
Открыть Аудиокниги
Категории
Открыть Журналы
Категории
Открыть Документы
Категории
,
2006 .
Visit the GOLD Website at www.goldcopd.org
,
2006 .
,
2006 .
2007
54.12
52
616.23+616.24
52 ,
/ . . . .. .: , 2007. 96 .,
.
GOLD (Global Initiative for Chronic Obstructive Lung Disease)
2006 . , , ,
, , ,
. $
: $
, .
, , , .
, , 2007
,
(2006)
GOLD*
Antonio Anzueto, MD
(Representing the American
Thoracic Society)
University of Texas
Health Science Center
San Antonio, Texas, USA
Peter Calverley, MD
University Hospital Aintree
Liverpool, UK
Teresita S. deGuia, MD
Philippine Heart Center
Quezon City, Philippines
Yoshinosuke Fukuchi, MD
(Representing the Asian Pacific
Society for Respirology)
Tokyo, Japan
Christine Jenkins, MD
Woolcock Institute
of Medical Research
Sydney, NSW, Australia
Nikolai Khaltaev, MD
(Representing the World Health
Organization)
Geneva, Switzerland
James Kiley, PhD
(Representing the National Heart,
Lung, and Blood Institute,
National Institutes of Health,
Department of Health
and Human Services)
Bethesda, Maryland, USA
Ali Kocabas, MD
Cukurova University
School of Medicine
Balcali, Adana, Turkey
MD
Mara Victorina L opez,
(Representing the Latin American
Thoracic Society)
Montevideo, Uruguay
Ewa Nizankowska$Mogilnicka,
MD
University School of Medicine
Krakow, Poland
Klaus F. Rabe, MD, PhD
Leiden University Medical Center
Leiden, The Netherlands
Roberto Rodriguez Roisin, MD
Hospital Clinic
Barcelona, Spain
GOLD*
Jan Zielinski, MD
Institute of TB and Lung Diseases
Warsaw, Poland
Leonardo Fabbri, MD
University of Modena
& Reggio Emilia
Modena, Italy
James C. Hogg, MD
St. Pauls Hospital
Vancouver, British Columbia,
Canada
A. G. Agusti, MD (Effective
June 2006)
Hospital Universitari Son Dureta
Palma de Mallorca, Spain
Christine Jenkins, MD
Woolcock Institute
of Medical Research
Sydney, NSW, Australia
Antonio Anzueto, MD
University of Texas Health
Science Center
San Antonio, Texas, USA
Ewa Nizankowska$Mogilnicka,
MD
University School of Medicine
Krakow, Poland
Peter J. Barnes, MD
National Heart and Lung Institute
London, UK
Sean Sullivan, MD
University of Washington
Seattle, Washington, USA
A. Sonia Buist, MD
Oregon Health & Science
University
Portland, Oregon, USA
Peter Calverley, MD
University Hospital Aintree
Liverpool, UK
Marc Decramer, MD (Effective
June 2006)
University Hospital
Leuven, Belgium
Yoshinosuke Fukuchi, MD
President
Asian Pacific Society
for Respirology
Tokyo, Japan
University of Minnesota
Minneapolis, Minnesota, USA
Jim Reid, MD
Dunedin School of Medicine
University of Otago
Dunedin, New Zealand
Sanjay Sethi, MD
VA Medical Research
Buffalo, New York, USA
Peter Sterk, MD
Leiden University Medical Center
Leiden, The Netherlands
GOLD,
Lorenzo Corbetta, MD
Universit` di Firenze
Firenze, Italy
Maia Gotua, MD, PhD
Center of Allergy & Immunology
Tbilisi, Georgia
Huchon, MD
Gerard
University of Paris
Paris, France
Yousser Mohammad, MD
Tishreen University School
of Medicine
Lattakia, Syria
Bart Celli, MD
Caritas St. Elizabeths
Medical Center
Brighton, Massachusetts, USA
M.W. Elliott, MD
St. Jamess University Hospital
West Yorkshire, UK
Peter Lange, MD
Hvidovre Hospital
Hvidovre, Denmark
Carlos M. Luna, MD
President, ALAT
Buenos Aires, Argentina
Dennis Niewoehner, MD
Oliveira, MD
Julio
Fernando Lundgren, MD
Jose R. Jardim, MD
Brasil
Vesna Petrovic, MD
JUDAH Association for Asthma
and COPD
Serbia
.....................9
.......................................................10
..............................................................11
1: ......................................15
......................................16
..................................................16
...........16
.....17
......................................17
........................17
.........................................18
,
.........................19
.............................................19
.....................19
.........................................19
2: ...................................21
......................................22
........................................................22
..............................................22
..............................22
.......................................24
...........................................24
25
...........................25
................................26
.........................................26
3: ...................................28
......................................29
........................................................29
................................................29
.......................................................29
..................30
...................................30
...30
.........................30
....31
..........................31
...........................31
........................................................31
..............................................31
$ ..............32
......................................................32
...................................32
.........................................32
4: ,
............................34
......................................35
........................................................35
.............................................35
........................................................36
.........................36
..................36
...........................36
............37
...................................37
.............................................38
............38
..........................38
.............................38
............................38
..........................39
.....................................................39
.........................................39
5: .....................................40
........................................................41
1:
.......42
......................................42
...................................42
.................................42
..............................................43
...............................................43
............................43
........................43
......................44
....................................44
...................44
...............................................44
.......................44
......................................45
() ....45
..............46
.............47
.............................55
............47
..............................47
.......................47
1) ........................... 47
3:
.........57
......................................57
........................................................57
........................................................58
.............58
...........58
...59
..........................59
..........59
........................................60
2) .......................................61
........62
..................................62
...........47
..................................48
.......48
..................................49
.......................49
..........49
....................49
)
................................49
.........................................49
............49
..............................49
............49
.............................49
..............50
.............50
2:
...............................................51
......................................51
........................................................51
.................................................51
......................51
....................................52
........................52
...........................53
................................54
....................55
.....................55
...........55
.........................................63
..........................63
...63
..................63
............................63
....64
.....64
.............................................64
1) 64
.......................................64
(,
) ..............65
...................................65
(,
) ......................65
.............65
.................................65
() ...........................66
..............................66
......................66
........................................66
66
................................67
.........................68
......................................68
................................69
.....................70
...................................70
..................70
.........................70
......................................70
.............................71
.......................71
..................................71
.............................71
4:
.......................................73
......................................73
........................................................73
.................74
.................................................74
........................74
............74
......................74
74
...............74
...........75
.......................75
....................75
..........................75
..........................................76
..................76
..................................................76
....76
.................77
......................77
......................................77
.................78
...................78
..........................80
....................80
.........................................80
6:
............................................92
......................................93
........................................................93
...................................................93
....................93
.........................................94
.........................94
.....94
GOLD ....................95
.........................................95
!
GOLD ,
$
( 2006 ). $
, $
,
,
.
,
,
. $
$
, $
.
GOLD, $
, $
. $
,
,
. ,
, $
$
, $
,
$
. $
GOLD .
,
$ .
, $
, $
$
.
, $
$
2006
. $
, $
, . $
,
, $
. $
,
. $
, $
.
, $
.
, , $
$
2006
$
, $
.
,
,
,
..
()
$
. $
, ,
2020 . ,
,
, $
(). ,
,
,
$
.
$
, , 1998 . $
$
, ()
(GOLD Global Initiative for Chronic
Obstructive Lung Disease). $
GOLD
,
.
GOLD
, ,
2001 . $
Romain Pauwels ();
$
, , , $
. $
$
,
. $
,
, , $
10
,
2001 .
2001 .
( GOLD), $
.
,
. $
GOLD, .
GOLD,
,
, . $
GOLD , ,
, $
, $
, $
, $
.
$
GOLD,
.
GOLD .
$
,
, , , ,
, , ,
, $
.
A. Sonia Buist, MD
, ,
GOLD
,
. $
, $
. $
[1], , , $
$
[2].
GOLD
. GOLD $
,
, $
$
.
$ $
(.. , $
), $
, $
, .
GOLD
( , )
GOLD
,
.
,
. $
$
, . $
$
, .
$
, ,
. , $
,
, $
. $
,
$
,
,
.
,
GOLD, $
,
. GOLD $
,
$
, $
$
. $
. $
, .
GOLD $
, ,
,
$
[2].
GOLD $
, , ,
.
, $
.
$
,
, $
. , )
, $
, $
, $
.
GOLD $
,
4 : 1) )
; 2)
; 3) ; 4) )
.
, ,
, ,
. ,
, $
.
)
.
11
$
,
$
. $
$
.
$
GOLD $
$
, ,
$
, $
$
, $
.
GOLD GARD ($
),
2006 . GOLD
GARD
$
.
. .
GOLD 2001 . $
GOLD , $
GOLD
,
GOLD, $
$ GOLD. $
GOLD
2003 . , $
2001 . 2002 .
2004 .,
2005 .
,
.
PubMed (http://www.nlm.nih.gov)
,
: 1) )
, , , 19+ , )
, ,
, ; 2) )
,
, , 19+ ,
, , . $
, , PubMed,
$
,
(
).
12
.
( $
), $
. $
(,
, ), $
,
GOLD.
,
. $
GOLD . $
$
, , $
;
GOLD. $
.
,
(100200 ), $
5, $
. , $
, $
$ GOLD
(www.goldcopd.org).
. 2006 .
2005 . GOLD $
. $
, $
, 2001 .,
$
$
. 2005 .
.
$
, $
,
,
GOLD, $
,
.
2006 . $
. 2 $
. $
2005 .
, $
. 2005 . $
$ GOLD.
,
2006 ., $
,
GOLD , $
2006 . 2006 .
, $
, $
.
2006 .,
, $
31 2006 .
( 2005 ., 2006 .) $
GOLD GOLD $
,
. GOLD $
50 ,
. $
GOLD $
; $
. $
. $
GOLD
.
1. ,
$
, $
, $
$
,
.
2. $
, , $
ATS/ERS,
, $
$
.
3. $
:
I ; II ; III
; IV .
0 , $
2001 .,
, $
, , $
(
, ,
),
I ( ). $
,
.
4. $
, , $
$
1/ <0,7 $
. $
(1/) $
,
. $
, $
$
.
5. 2
, $
. $
,
, , $
40
$
, I ( ) $
. , ()
I ) $
$
, 40
40 , . $
.
6. , $
,
. ( , ,
,
, $
, $
; $
,
$
. . .) $
. $
,
$
, $
.
7. 4 , $
, $
; $
,
. $
.
8. $ $
: 1) $
; 2) ;
3) ; 4)
. $
.
,
$
13
$
.
9. 4 ( ) $
: )
)
, ,
/ ,
, )
.
10. ,
$
$
.
,
$
. , $
,
$ $
.
5 $
$
. $
$
, ( A). $
,
[3]. \
GOLD, $
. GOLD $
$
[4];
,
.
, , $
().
, .
.
.
, ($
().
), ; post hoc ;
.
. $
, , , ,
, .
. $
$.
$.
, $
, ,
. , $
.
1. World Health Report. Geneva: World Health Organization. Available from URL: http://www.who.int/whr/2000/en/statistics.htm; 2000.
2. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future pro$
jections. Eur Respir J 2006;27(2):397$412.
3. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. Systematic reviews and meta$analyses on treatment of asthma:
critical evaluation. BMJ 2000;320(7234):537$40.
4. Guyatt G, Vist G, Falck$Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations? ACP J Club
2006;144(1):A8$9. Available from URL: http://www.evidence$basedmedicine.com
14
1:
()
,
,
,
.
,
.
.
, ,
(
), (),
.
,
.
,
.
(
),
,
.
()
,
,
. ,
,
.
,
: ,
,
,
16
.
,
.
.
,
.
,
,
( ),
(),
(. 11).
.
,
,
; ,
.
,
.
, ,
GOLD.
,
(), ,
. 11. ,
( )
, .
, ..
3
, ,
,
.
.
,
; ,
.
,
,
, [1]. ,
(
) ,
[2]. ,
, , 25% 65
, 17% [3].
, ,
;
, , ,
, , ,
, , [4].
;
[58]. ,
(, ), ,
,
.
,
.
.
,
.
,
.
,
,
,
,
.
, , ,
.
, ,
, , .
,
(. 11).
.
(,
1/ <0,70 1 <80, <50 <30%
);
.
,
1/
0,70 ,
[9].
,
1/
,
.
() 1/,
11.
,
1
I
1/ <0,70;
1 80% ;
II
1/ <0,70;
50% 1 < 80% ;
III
1/ <0,70;
30% 1 < 50% ;
IV
1/ <0,70;
1 <30% 1 <50%
: 1 1 ;
;
(PaO2) 8 (60 . .)
CO2
(PaCO2) 6,7 (50 . .) .
17
12.
GOLD
.
,
: I ; II ; III ;
IV . 0 ,
2001 .,
, , ,
( ,
, ),
I ( ).
,
,
.
, , 5%
,
,
1/. ,
1/.
,
1,
.
(
, 400 ) [10]
. ,
,
[9]. , ,
[11].
1/ 1
,
(,
1
())
,
()
.
, (
).
. ,
,
18
,
,
.
,
.
, ,
,
.
, (. 12),
,
.
,
.
,
(, ,
)
.
,
.
I
(1/
<0,70; 1 80% ).
,
.
, .
II
(1/ <0,70; 50% 1 < 80%
) , , ,
,
.
.
III
(1/ <0,70; 30% 1 < 50%
), ,
,
,
.
IV
(1/ <0,70; 1 <30% 1
<50%
).
(PaO2) 8
(60 . .)
(PaCO2)
6,7 (50 . .)
, .
,
( ).
.
( IV),
1 >30% ,
.
, .
, 1520%
,
[12].
,
[13].
,
,
[14].
, ,
, [15].
,
,
,
, ; ,
,
,
,
.
,
, ,
, ,
, ,
.
,
. 12.
,
CD4+ T
,
CD8+ T
,
,
, ,
.
,
.
(. 12). ,
,
[16],
. ,
,
[17].
,
,
[18]. ,
,
. [19, 20]
,
( 10%) 40 ,
;
.
, [21]. ,
, ,
[22].
, , ,
.
,
,
[23].
1. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL.
Patterns of comorbidities in newly diagnosed COPD and asthma in
primary care. Chest 2005;128(4):2099107.
2. Agusti AG. Systemic effects of chronic obstructive pulmonary dis
ease. Proc Am Thorac Soc 2005;2(4):36770.
3. van Weel C. Chronic diseases in general practice: the longitudinal
dimension. Eur J Gen Pract 1996;2:1721.
19
20
2:
,
,
, .
,
,
,
;
,
.
,
,
.
( ,
),
(
, ,
,
,
).
,
. ,
.
,
[1].
: ,
2003.
(2003 European Lung White Book) [2],
, (http://www.who.int),
/
(World Bank/WHO
Global Burden of Disease Study) (http://www.who.int/topics/
global_burden_of_disease),
,
(US Centers for Disease
Control and Prevention http://www.cdc.gov)
(UK Health
Survey for England http://www.doh.gov.uk).
,
, ,
. ,
,
,
;
,
. ,
,
(
, ).
22
,
,
[3, 4].
:
;
;
.
. , ,
6% ,
[3]. , ,
[5],
, I ( )
(, ),
,
[5].
,
,
,
,
.
,
,
,
, 40
,
I ( )
[69].
,
,
,
,
,
.
,
,
,
[10].
,
,
(,
),
. ,
1/, 0,70,
,
(.. )
(..
) 50 [1113].
()
1/,
[14, 15].
.
,
,
, , ,
.
, ,
.
1/ ,
, .
,
.
[16].
,
.
, 28 1990
2004 . [3],
[17] ,
( I ( ) )
, ,
40 ,
40 , , .
(Latin American Project for the
Investigation of Obstructive Lung Disease, PLATINO)
( I (
) ) 40
, , , .
( I (
) )
(. 2%1)
60 .
(18,4% ()) (32,1%
. 2%1.
[6]
:
1 / <0,70 I ( ) .
23
()). /
,
.
[6].
, 12
, ,
30
6,3%. ( 2 )
12 ;
(3,5%)
, (6,7%) [18].
, ,
.
,
,
,
,
[1921]. , ,
( I
II ),
, ,
, .
[22] (
, ,
),
,
.
( III
IV )
, ,
.
(,
)
,
. ,
,
19
[2].
,
, , . 2000 .
8 .
24
/ , 1,5 .
673 000
[23].
,
,
().
,
1,68 1000 , 1,8%
, ,
(1,93 1,42% ) [8, 24, 25].
;
(WHO Evidence for Health
Policy Department, http://www.who.int/evidence).
. 1968 .
()
8
. 1970
, ,
.
9 10
,
( 490496 9
J4246 10).
,
,
.
,
,
,
.
, ,
.
[8, 24, 25], ,
1990 ., 2020 .
.
, .
.
,
, ,
,
,
, .
.
6
1970 2002 . [26] , ,
,
(. 2%2).
1997 .
:
[7].
, ,
,
.
.
1990 ,
,
[21].
1970 . 2000 .
,
(59 936 59 118
),
, [27].
, ,
.
[8, 24, 25] ,
1990 2020 .;
,
,
, .
(
,
), (
, , ,
,
) [2].
. ,
. 2%2.
6
1970 2002 . [26]
6% ,
56%
(38,6 . ) [2]. 2002 .
18 . ,
14,1 . [28].
[7].
,
[29]
.
, ,
,
(. 2%3).
,
. ,
,
1987 .,
1
25
. 2%3.
[29]
. American College
of Chest Physicians, 2002.
(5409 )
2,7
(2001 ) [30]. 1992 .
Medicare (
65 )
1 (8482
) 2,5 ,
(3511 ) [31].
.
,
,
,
[32].
,
.
,
.
,
,
,
.
,
26
,
,
.
,
,
DALY
(DisabilityAdjusted Life Year ,
. . .) [8, 24, 25]. DALY (DALYs)
,
. 1990 .
12 DALYs ,
2,1% . ,
5 DALYs 2020 . ,
, ,
.
, 20 ,
,
.
1. Tirimanna PR, van Schayck CP, den Otter JJ, van Weel C,
van Herwaarden CL, van den Boom G, et al. Prevalence of asthma
and COPD in general practice in 1992: has it changed since 1977?
Br J Gen Pract 1996;46(406):27781.
2. European Respiratory Society. European Lung White Book:
Huddersfield, European Respiratory Society Journals, Ltd; 2003.
3. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS,
Mannino DM. Global burden of COPD: systematic review and
metaanalysis. Eur Respir J 2006.
4. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD
prevalence estimates: what is the true burden of disease? Chest
2003;123(5):168492.
5. van den Boom G, van Schayck CP, van Mollen MP, Tirimanna PR,
den Otter JJ, van Grunsven PM, et al. Active detection of chronic
obstructive pulmonary disease and asthma in the general popula
tion. Results and economic consequences of the DIMCA program.
Am J Respir Crit Care Med 1998;158(6):17308.
6. Menezes AM, PerezPadilla R, Jardim JR, Muino A, Lopez MV,
Valdivia G, et al. Chronic obstructive pulmonary disease in five
Latin American cities (the PLATINO study): a prevalence study.
Lancet 2005;366(9500):187581.
7. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS,
Thun MJ, et al. Epidemiology and costs of chronic obstructive pul
monary disease. Eur Respir J 2006;27(1):188207.
8. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS,
et al. Chronic obstructive pulmonary disease: current burden and
future projections. Eur Respir J 2006;27(2):397412.
9. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA,
Menezes AM, et al. The burden of obstructive lung disease initia
tive (BOLD): Rationale and Design. J COPD 2005;2:27783.
27
3:
(. 31), ,
. ,
,
.
. ,
, ,
;
(
); /
.
.
1.
, ,
.
,
,
(/, )
.
.
,
,
,
.
.
,
,
. ,
,
,
[1, 2].
,
,
, , , ,
.
(
)
( 20 )
[3],
,
. ,
.
.
1 [4],
.
,
[5].
,
,
,
.
31.
( )
29
. 31.
,
. 1
,
.
, /
[6];
.
, 2
(2q) [7], , , ,
.
,
,
1 (TGF1) [8],
1 (mEPHX1) [9] (TNF)
[10].
( 1) [7].
, ,
(. 31).
,
.
,
,
[11, 12] (/,
) [1316]
.
30
, .
,
,
.
.
.
,
1
.
, ,
(.. )
[11].
, ,
[17, 18],
.
[12]. ,
,
.
,
[9].
(
environmental tobacco
smoke, ETS)
[19] [20]
[21, 22].
, ,
[23, 24].
.
[1416, 25].
,
.
NHANES III, 10000
3075 ,
. , ,
,
19,2% 31,1%
[16].
(American Thoracic Society),
,
1020%
, [26].
.
, , (,
..)
.
,
(
) [2733];
[32,
33] .
3 .
,
. ,
.
, SO2
,
.
, [34, 35]. ,
2 . [36].
.
.
, ,
,
.
.
,
,
[37]. ,
.
,
,
[3840].
( )
[41].
,
,
. ,
,
1 [42].
,
. ,
(,
)
.
.
,
.
,
,
. ,
[43].
,
[44].
,
. [45, 46]
,
, ,
,
.
,
, [44, 47, 48].
,
.
( )
[49];
,
[50],
[51].
[38, 41, 52].
( ).
,
.
,
,
. ,
31
()
, ;
[53].
,
[54]. ,
, ,
,
[55, 56].
.
,
[57].
/
[58].
[59].
,
.
(Tucson Epidemiological Study of Airway Obstructive
Disease) ,
12 ,
( ) [60].
, 20%
,
[61].
1. Celli BR, Halbert RJ, Nordyke RJ, Schan B. Airway obstruction in
never smokers: results from the Third National Health and
Nutrition Examination Survey. Am J Med 2005;118:136472.
2. Behrendt CE. Mild and moderatetosevere COPD in nonsmok
ers. Distinct demographic profiles. Chest 2005;128:123944.
3. Anthonisen NR, Connett JE, Murray RP. Smoking and lung func
tion of Lung Health Study participants after 11 years. Am J Respir
Crit Care Med 2002;166(5):6759.
4. Stoller JK, Aboussouan LS. Alpha1antitrypsin deficiency. Lancet
2005;365(9478):222536.
5. Blanco I, de Serres FJ, FernandezBustillo E, Lara B,
Miravitlles M. Estimated numbers and prevalence of PI*S and
32
33
4
,
4: ,
*
, ,
.
,
.
;
, .
,
.
( )
( ).
.
, ,
,
[1].
:
( ), (
, )
CD8+ ( ).
,
.
.
,
( ),
.
,
, ,
,
, ,
.
;
.
;
* , ,
GOLD (http://www.goldcopd.org).
471.
(,
>2 )
: ,
T CD8+ (),
.
: ,
(
), [3].
(
<2 )
: ,
T (CD8+ > CD4+) B, ,
,
.
: ,
, ,
( );
[4].
( )
:
T CD8+.
: ,
[5].
:
, .
: ,
;
1.
:
T.
: ,
,
[6].
, 35
. 471.
,
,
.
.
7
,
,
,
[2] (. 471).
, .
,
.
,
[7].
.
(. 471).
472.
. .
.
.
[8].
. ,
.
, .
[9].
T7.
CD4+ CD8+,
CD8+/CD4+. T CD8+ (Tc1) Th1,
CXCR3 [9].
CD8+ ,
.
B7.
, ,
[4].
.
.
.
.
473. ,
:
: , B4 (LTB4)
T
: , 8 (IL8)
.
: ,
(TNF), IL1 IL6
.
: , (TGF)
.
36 ,
,
, [1]
(. 472).
.
,
[10],
(
),
( )
( ). . 473
.
[11].
(,
, 8)
, .
.
,
[12].
.
[13].
474. ,
1
1
G
3
B, K, L, S
()
8, 9, 12
14
( 14)
:
, ,
.
,
. ,
,
,
.
,
,
,
,
,
,
.
,
.
(. 474).
,
,
,
, .
,
,
, , ,
,
(. 475, . 472).
, .
475.
++
+++
CD8+ T (Tc1)
++
+
CD4+ T (Th2)
IL8
TNF, IL1, IL6
NO +
IL8
IL5, IL13
NO ++
+++
+++
: NO ; +, ++, +++ , .
, 37
. 472.
CD4 (Th2)
CD8 (Tc1)
. ,
,
[14].
,
. , , 1, ,
,
.
,
1 1/, ,
,
1 [4].
(
), .
, 1,
,
.
38 ,
,
(
),
.
,
[15].
, ,
,
,
.
.
.
PaO2
(VA/Q).
VA/Q;
,
.
VA/Q.
,
,
. ,
. ,
.
;
(EGFR) [16].
,
:
/ [17].
,
, .
476.
:
: ,
:
C
.
(
).
,
,
,
[18, 19] (. 476).
.
/ . ,
,
[20].
,
TNF, IL6 .
, C
(C) [21].
;
.
, ,
.
,
[22].
, TNF, LTB4 IL8,
.
,
[23].
, [24].
, VA/Q,
.
1. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pul
monary disease: molecular and cellular mechanisms. Eur Respir J
2003;22(4):67288.
2. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive
pulmonary disease. Lancet 2004;364(9435):70921.
3. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and
structural bases of chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 2001;163(6):13049.
4. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al.
The nature of smallairway obstruction in chronic obstructive pul
monary disease. N Engl J Med 2004;350(26):264553.
5. Cosio MG, Majo J. Inflammation of the airways and lung parenchy
ma in COPD: role of T cells. Chest 2002;121 (5 Suppl):160S5S.
6. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic
obstructive pulmonary disease: current theories of pathogenesis
and their implications for treatment. Thorax 2005;60(7):6059.
7. Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J,
et al. Clinical, radiologic, and induced sputum features of chronic
obstructive pulmonary disease in nonsmokers: a descriptive study.
Am J Respir Crit Care Med 2002;166(8):107883.
8. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest
2002;121(5 Suppl):151S5S.
9. Barnes PJ. Macrophages as orchestrators of COPD. J COPD
2004;1:5970.
10. Barnes PJ. Mediators of chronic obstructive pulmonary disease.
Pharmacol Rev 2004;56(4):51548.
11. Rahman I. Oxidative stress in pathogenesis of chronic obstructive
pulmonary disease: cellular and molecular mechanisms. Cell
Biochem Biophys 2005;43(1):16788.
12. MacNee W. Oxidative stress and lung inflammation in airways dis
ease. Eur J Pharmacol 2001;429(13):195207.
13. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al.
Decreased histone deacetylase activity in chronic obstructive pul
monary disease. N Engl J Med 2005;352(19):196776.
14. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette
smoking. Eur Respir J 2004;24(5):82233.
15. ODonnell DE, Revill SM, Webb KA. Dynamic hyperinflation and
exercise intolerance in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2001;164(5):7707.
16. Burgel PR, Nadel JA. Roles of epidermal growth factor receptor
activation in epithelial cell repair and mucin production in airway
epithelium. Thorax 2004;59(11):9926.
17. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in
chronic obstructive pulmonary disease. Eur Respir J
2003;21(5):892905.
18. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD.
Chest 2002;121(5 Suppl):127S30S.
19. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X.
Systemic effects of chronic obstructive pulmonary disease.
Eur Respir J 2003;21(2):34760.
20. Similowski T, Agusti AG, MacNee W, Schonhofer B. The potential
impact of anaemia of chronic disease in COPD. Eur Respir J
2006;27(2):3906.
21. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between
chronic obstructive pulmonary disease and systemic inflamma
tion: a systematic review and a metaanalysis. Thorax
2004;59(7):57480.
22. Wedzicha JA. Exacerbations: etiology and pathophysiologic
mechanisms. Chest 2002;121(5 Suppl):136S41S.
23. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti AG.
Oxidative stress and airway inflammation in severe exacerbations
of COPD. Thorax 2005;60(4):293300.
24. Parker CM, Voduc N, Aaron SD, Webb KA, ODonnell DE.
Physiological changes during symptom recovery from moderate
exacerbations of COPD. Eur Respir J 2005;26(3):4208.
, 39
5:
4 : 1) ;
2) ; 3) "
; 4) .
( I II)
. "
( III) ( IV) "
"
,
.
, "
, "
"
.
,
"
"
.
"
, "
, :
;
;
;
;
;
;
.
"
, "
,
.
,
"
.
, ( )
, ( ) .
, , ,
.
"
;
, "
. "
( "
) .
,
, , "
.
"
.
"
, "
, ,
"
. , "
, "
,
. "
, "
,
.
,
, "
. "
, , "
"
.
.
41
1:
"
, "
/
.
.
,
,
. "
1/ <0,70 1 <80%
"
.
, "
, "
.
"
, "
x .
1 <50% "
"
.
"
, "
"
. "
,
.
"
(. 511). "
. "
1/ <0,70
1 <80% "
.
,
.
I ( ) "
.
"
"
"
. "
II (
) ,
[1]. ,
,
.
, I
( ), II (
).
, "
"
.
III ( )
511. ,
,
40 .
,
.
.
( ).
.
( ).
, ,
.
,
:
.
.
.
, "
. "
.
, "
/
42
,
, "
( , "
, "
). , ,
,
"
.
,
"
, .
, , "
, [2]. ,
, "
[3].
" "
, "
. "
"
(MRC) (. 512).
[4] "
[5].
"
.
"
"
, .
(,
), "
(, ).
, "
, ,
,
,
(,
) [6].
(, "
, ) , "
.
. "
[7] "
, "
/ .
,
,
.
[8].
"
. . 513
512.
MRC [4]
, ,
( )
,
" ,
, ,
, 100 ,
, ,
,
513.
(, )
"
.
. "
"
.
3 "
( ,
) "
[9], "
,
.
,
, ,
, .
"
. "
"
[10]; "
[11].
.
,
. I
( ),
III ( ) IV (
). "
43
"
.
, "
"
. "
, ,
, , " "
.
,
.
. "
[12].
[13]
(, "
, ),
.
()
.
, .
. , "
"
, / "
[14], "
.
"
"
:
, "
;
, ,
, "
, ;
;
"
,
,
"
;
"
, ,
;
, "
, , ,
" ,
[15];
44
, ", "
, "
;
, "
, "
,
, ;
;
, .
, "
. "
, "
[16, 17];
.
,
.
, "
"
, .
,
, "
, "
.
"
.
"
20 , "
[17].
, "
"
[18].
"
.
scalenae sternoclidomastoideus "
"
.
"
"
.
.
"
.
,
.
"
, "
, [19].
.
"
.
,
.
"
.
()1
, ,
. "
"
.
,
. "
, "
"
.
, , "
, "
. . 514
, "
.
"
, "
(
, ), , "
1"
( 1" ,
1),
(1/). "
[20] ,
, ( "
., , [20]).
. 511
,
1
. "
GOLD (Spirometry for Diagnosis of COPD: Insert for GOLD
Pocket Guide) " http://www.goldcopd.org
514.
.
,
,
.
, ,
.
,
.
,
[24].
.
,
, 12 .
1 ,
,
1 5% 100
( ).
1/
1.
, , , [20].
1 <80%
1/ <0,70,
.
.
1, . "
(. . 11).
. 511.
,
*
4,150
2,350
5,200
3,900
0,80
0,60
*
1
45
1/ <0,70
.
, "
1 .
,
"
("
, 400 ). "
,
"
"
[21]. "
1/
, "
,
.
, "
"
.
"
,
[22]. "
() (US National Health
and Nutrition Examination Survey) , "
90% ,
, " "
"
[23].
,
, . 1,
"
,
. ,
[25].
, "
"
"
, "
.
"
,
(. . 11) , "
, "
, "
.
"
,
"
, , "
46
, "
(.
. 12).
, "
,
, , , "
[27, 28]. "
. "
[29],
,
"
. , "
, ,
.
, "
, "
, "
[30].
MRC (. . 512).
"
;
"
, "
"
[31].
, "
( )
[32] "
[33],
"
[30]. "
,
[34].
"
[35, 36].
"
. BODE
(Body mass index, Obstruction, Dyspnea, Exercise
, , , )
, "
"
, "
[37]. "
BODE "
.
II ( )
"
.
%
.
, "
( "
) "
"
1, "
[38, 39].
1 (, 400 )
, , "
[40].
"
[39], 1,
,
, "
1 >200 .
(, "
, "
) "
/ . "
. 515.
%
.
, ,
"
, "
.
, , "
( "
, ), "
,
. ()
.
, "
() "
. ,
, "
, "
, "
, "
[41].
. "
( )
.
, 1 <50%
515.
,
.
6
, 12
, 24 .
, , 1.
, ,
.
.
: 400 2", 160
[20]. 1
1015
( 3045 ).
1 200 12% 1
[20].
1,
,
.
"
.
"
, "
. "
FiO2 (
FiO2 21%), "
, , "
.
, . ,
FiO2 2030 ,
"
, "
, "
. "
1 ,
.
1%. "
,
(<45 ), "
1". "
.
1" 1520% "
, , "
1".
"
"
,
47
516.
.
.
.
.
.
( ).
.
.
, / .
.
.
.
, .
, .
.
.
.
, .
.
.
.
.
, .
.
.
.
.
.
. ,
. , ,
, ( ,
, );
.
; ,
. "
. "
(. 516).
"
. "
,
. "
, "
, : 1)
, "
48
517.
*
:
?
?
, ()
?
?
" ?
:
, ? (
, , ,
.)
(, ),
?
" ?
" ?
" ?
" ?
" " (
) ?
:
?
?
?
" ?
(,
, )?
, , .
?
?
" ?
:
?
, () () ()? ,
, ? ,
?
*
. ()
.
; 2) "
; 3) "
; 4) "
; 5)
.
"
. 517.
"
.
"
. ,
.
"
.
, "
, "
.
.
"
, "
, "
"
: "
.
,
, "
(DL CO)
, "
, "
.
. "
, "
"
, O2
<8 (60 . .), "
O2 >6,7
(50 . .).
"
, "
(SaO2)
92% [42]. "
2.
"
"
, "
. "
.
. "
( "
30 . .), ",
,
.
, "
O2 "
.
%
. "
, "
.
" "
. "
, "
, , ,
" .
.
% %
. " "
, "
"
. "
.
.
, "
[43]. "
55%. "
, ,
[44]
25% . "
, "
[45].
.
.
, "
"
. "
(, "
) [46, 47].
.
, "
"
"
.
. , "
, "
(, "
6"
),
.
"
.
,
, , "
,
.
49
,
, , "
. , "
.
, "
. "
"
,
, "
.
"
, "
. "
, ,
.
"
.
. (, "
, , )
, "
, "
. (, "
, , ) "
, "
.
"
, "
, , "
.
, , "
. "
, "
,
.
50
2:
,
, "
.
"
,
( ).
, "
,
, "
.
"
.
,
,
"
, ,
.
"
.
, "
"
. "
, "
,
. "
, "
(
),
"
. "
"
, ,
.
, "
, "
,
, , "
, , , "
.
. "
[48].
,
"
"
.
,
, , .
"
. "
"
.
"
"
1996 . "
, "
(. 521).
,
521.
:
1996 . 49"
.
,
.
http://www.who.int/tobacco/resources/publications/fctc/en/index.html
51
[49]. "
"
"
[50]. "
"
. "
, ,
..,
.
"
[51].
"
,
[52, 53].
, . 2 ,
, "
,
"
[53, 54].
"
"
522.
:
:
[60]
1. ,
,
.
2. ,
.
3.
,
.
4. ,
.
5.
.
6. : ,
, .
7. 1"
, ,
, ,
,
.
8.
.
52
.
"
"
[55]
[56].
,
,
.
, , ,
. "
,
;
. "
:
, ,
.
: "
,
;
( "
"
); "
;
. ,
, "
990 13 000
[57]. "
212
873 (3201400 )
[58].
%
. "
,
,
[59].
,
, , , "
. "
"
. "
,
, "
, . "
"
:
[60]. "
. 522.
"
(. 523),
"
,
[6063]. "
, "
(. 524) [60],
, "
, "
,
.
, (. 521) [59].
"
,
. , "
. ,
, ,
.
. "
, "
,
,
[64]. (3") , "
,
510% [65]. , "
[65, 66]. ,
,
"
.
"
[67, 68].
,
, . "
, 10,9%
6 [67].
(, "
, , "
), "
2030% [68]. "
, , "
35% , 5 "
22% [55].
,
. "
,
"
[59, 60]. , "
, :
523.
,
[6063]
1. :
.
, ,
.
2. :
.
,
.
3. : .
,
(, 30 ).
4. : .
;
;
, ;
,
; .
5. : .
.
524.
[60]
, ,
, .
,
,
.
.
,
, ,
,
,
.
,
.
,
( ,
, , , "
, );
, "
( , "
);
(
, , ,
, ,
).
53
"
, "
[67].
.
[5961], , "
, .
"
: "
, ( 10 ),
, .
.
,
( , ,
, ,
)
[60, 69]. "
, "
[70],
"
"
. "
,
[59].
"
8 ,
; "
"
,
[60, 71].
"
, . "
. 521.
"
54
,
. "
"
, "
"
.
, "
, .
. "
, "
, "
4
8 . "
, 4
, 4 .
"
,
.
,
, "
, "
. , "
,
,
. , ,
, "
. ,
( )
15 .
"
, "
, ,
, "
" "
. "
4 "
, 2 [72].
. ,
[73] "
[59, 69, 74]. "
,
,
"
30%,
35% [73]. "
[69].
"
,
,
[7577].
19%
31%
"
[7881]; ,
, . ,
, "
, "
. , "
( ,
)
"
, "
,
[8284]:
"
"
;
,
,
, "
, ;
, "
,
"
"
.
,
"
. ,
, "
"
.
. "
"
"
,
, , "
.
"
, .
"
, "
[80].
"
,
. "
"
.
, "
,
.
, "
" .
"
;
. "
,
"
, "
,
. ,
,
, "
, "
. "
"
.
"
( , ,
"
) "
. "
.
,
"
.
"
, "
.
,
.
"
"
, "
55
, "
"
.
"
"
"
"
,
, "
"
.
,
56
,
.
"
; "
" "
, "
.
.
, ,
,
,
, "
.
3:
;
,
(
).
.
(
)
,
.
,
(>15 )
( ).
,
,
(
). ,
/ .
(
).
.
2,
, (
).
,
(
).
1 <50% (
III IV )
(
).
.
, ,
,
.
(. 5, ),
.
(. 5
3
1)
.
.
(. . 1
1)
,
.
,
,
.
/ ( ).
).
65 ,
65 1 <40% (
B).
5
3
1. ,
57
, .
, ,
,
.
,
[8588] (
),
,
[89].
,
,
.
.
,
,
25% [55] (
).
[90, 91] (
). ,
,
(advance directives)*
[92] (
).
:
, ,
.
, ,
* , :
,
,
,
.
,
(
),
,
( :
/ . .., .. .:
, 2000). . .
58
,
.
, ,
, ,
, .
.
,
,
, ,
,
.
,
.
,
.
, :
,
,
, ,
.
,
: ;
;
;
; ; ,
;
;
,
(. 5
3
2).
;
.
.
(. 5
3
3).
,
.
,
, ,
(, ).
case management**
** , , ..
. . .
[93]. ,
,
,
[94].
.
,
.
,
[88] (
),
. ,
,
.
,
,
.
/ ,
[95],
,
.
,
,
.
65% , 88%
,
;
.
,
, , 4
12
,
12
[96].
,
[97].
,
,
. ,
,
[55, 98100] (
).
.
,
.
.
,
.
,
5
3
2.
:
IIII ( )
:
IV ( )
:
,
5
3
3. ,
?
?
?
?
, ?
, ?
, ?
?
.
. ,
, .
59
5
3
4. ,
, /
Per os
, ,
2
()
100200 ()
0,05% ()
100, 200 ( )
5 ()
46
0,1; 0,5
46
0,2; 0,25
46
0,024% ()
400, 500 ()
2,5; 5 ()
4,512 ( )
12+
2550 ( )
12+
20, 40 ()
0,250,5
68
100 ()
1,5
79
18 ()
24+
2
/
200/80 ()
1,25/0,5
68
75/15 ()
0,75/4,5
68
200600 ()
( )
100600 ()
240
, 24
, 24
50400 ( )
0,20,4
50500 ( )
100 ()
40
40
2
/
4,5/160, 9/320 ()
560 ()
4, 8, 16 ()
: , .
.
,
,
.
, [101],
,
.
, ,
.
,
,
60
, ,
,
( , ,
..),
.
,
, . 5
3
4.
.
, 1
,
[102],
, ,
,
.
,
[103]
. ,
,
1 [104, 105].
,
,
I
( ) , , [6]
( ).
[106109] (
) (. 5
3
5).
,
.
.
.
, ,
,
.
,
.
, ,
.
,
,
. ,
,
.
,
, .
, ,
,
.
[110, 111].
,
[112].
1
[106109]. .
2,
,
,
5
3
5.
2, ,
[113] (
),
[114] (
).
,
,
1
[115118] ( ).
,
[119122] (
).
2 [120]
[119121].
[123]
[124].
,
, .
,
,
.
2. 2
2 ,
.
,
[125] (
).
2
, ,
, .
2
46 [126, 127] (
). ,
61
[128].
2,
, 12 ,
[129132] (
).
. 2
,
,
.
, 2,
,
,
.
(
[133])
[134],
,
. O2
,
2 [135],
.
, ,
2
.
.
(
, ,
)
3.
2
,
[136].
3 1 [137].
,
2,
8 [126] (
).
24 [119,
138, 139] ( ).
.
, , ,
,
,
. ,
.
.
, 21
62
18 /
[140].
, ,
.
, ,
.
,
,
[141].
,
,
, .
,
.
.
.
, , ,
,
[142146].
,
. ,
,
[142],
, (
). ,
,
.
,
, .
. ,
,
,
,
, [144, 145] (
).
,
.
(
) (
).
, ,
, ,
.
( ,
).
,
450.
.
,
;
. 5
3
6.
.
. ,
2
1, ,
90 [126, 147,
148] ( ).
2,
/
[126, 146151],
[126, 152].
,
,
.
.
, ,
.
4: .
.
(2 )
,
.
[153],
1,
,
,
.
,
,
[38, 100]. ,
, ,
.
.
[154, 155],
5
3
6. ,
(PaO2 <6 , 45 . .)
( )
()
1
, .
,
.
[156158],
,
.
,
,
[159, 160].
,
,
(
).
.
1 [98100, 161].
1 <50%
( III IV
) (,
3 ) [162165] (
). ,
[140] ( ),
[166].
,
63
[167],
,
. 2
,
[162, 164, 165, 168, 169]
( ).
.
. ,
[98, 100].
[98, 170],
[161].
[171]. ,
.
.
,
.
,
.
,
2
,
[112].
,
S
.
1 <50%
( III IV
) (,
3 )
.
.
.
. 5
3
1
.
( I
)
.
,
.
, ,
,
,
( ).
,
( ).
,
, .
,
,
( B).
,
,
64
.
[172]
50% [173, 174] (
). ,
,
[175],
[176].
() [177].
65 [178, 179].
, ,
65
1 <40% [180] (
B).
1 .
1
1.
,
,
( ).
. , ,
[181183];
5 , ,
[184].
. 5
3
1. *
II
III
IV
1/ <0,70
1 <30%
1/ <0,70
1/ <0,70
1/ <0,70
1 <50%
1 80%
() ;
( )
( );
* 1.
,
[185, 186]
( ).
(,
) (, ,
, ).
,
[187189].
[190, 191],
, , .
,
(
D).
.
, , N
, ,
,
[192195]
( ).
N
,
[196].
(,
). ,
,
[197, 198].
,
[199].
. ,
,
[200]. ,
(
D).
. ,
,
,
65
. 5
3
2. ,
.
, ,
(, ,
, )
,
.
,
. ,
,
. ,
, ,
,
(
),
[201,
202]. ,
.
().
.
, ,
[203].
, ,
,
,
[204208].
5
3
7.
( )
( )
( )
( )
,
( )
( )
( )
( )
,
( )
( )
66
,
.
,
.
,
II ( ), III
( ) IV ( ),
,
, (
), .
,
(. 5
3
2).
ATS/ERS (
,
) [209].
;
. 5
3
7
[89, 210220].
18%,
11%,
87% .
6
49 [221]. ,
, [124].
.
,
,
,
,
[222] (
). ,
[223225].
,
,
, (
).
,
, .
.
,
.
,
[214, 215, 226].
.
, 68
( D).
,
.
.
, ,
,
, [227] (
).
. ,
,
, MRC
(. . 5
1
3).
5 [227] (
).
.
[224].
. ,
, , ,
,
.
,
, [224] (
).
.
;
,
.
.
,
,
,
.
(,
6 ).
.
:
,
, , [228].
10 45 ; ,
50%
.
(VO2 max),
[229].
, ,
28 ,
,
[221].
4 10 ,
[213].
[230],
. ,
, ,
,
,
20 .
, 6080%
.
.
,
,
[231, 232].
[233235]
( C).
,
[236]
[237],
, ,
.
,
,
.
6 ;
, (
) [238240].
,
[241]. ,
, (,
20 ).
67
,
,
.
.
,
,
,
[242, 243].
,
[244].
.
,
; ,
.
[209]. 25%
IIIV (
)
, [12, 245, 246].
[13, 247,
248] ( ).
. ,
,
.
, ( ,
..)
.
, ,
[249251].
,
[249, 250].
,
.
,
;
, ,
[252].
(, )
,
,
[253].
,
68
[254, 255].
.
,
,
, .
.
,
. :
;
;
;
;
,
(,
) .
,
.
.
,
(,
Chronic Respiratory Disease Questionnaire [152], St. George
Respiratory Questionnaire [256]),
,
.
,
Medical Outcomes Study Short Form (SF36) [257],
. Hospital Anxiety and
Depression Scale (HADS)
[258].
.
,
, ,
, ,
11 597 [259].
, ,
, (6 , 18 )
[225] (
).
,
,
, ,
,
.
, .
.
,
IV (
) [190, 260], :
, ,
.
2
8 (60 . .)
/
90% SaO2,
.
,
(>15 )
[261, 262].
, ,
,
[263].
,
[261],
[262] .
,
[264, 265].
,
,
.
[266].
IV ( )
:
2 7,3 (55 . .) Sa2 88%
(
B);
( ),
, ,
.
http://www.thoracic.org
,
.
, 2435% O2 .
,
CO2.
, ,
.
,
;
.
,
(, ),
,
.
,
.
15 , . ,
,
Sa2
90%.
,
/
[267, 268]
( A).
,
[269,
270].
, ;
, [271].
,
,
[272].
,
,
,
.
69
(
) ,
,
, .
( )
, , ,
. , ,
[273, 274] ( B).
.
,
[275].
,
, [276, 277].
.
,
,
12 / [278].
2
6,7 (50 . .). ,
,
,
3 /
[279]. ,
2 >9,3 (70 . .),
[278, 280], ,
2 >9,3 (70 . .)
(
).
,
(, ,
).
[281].
(
, ,
)
(.
4: ).
IV ( )
CO2.
70
,
,
,
[282].
()
,
[283].
,
O2
[284]. ,
, ,
,
[285].
.
,
,
.
.
,
[286] (
).
, ,
,
.
.
,
.
,
.
,
,
[287].
,
. ,
, 50%
[288].
()
,
[289]
( /,
) [290,
291].
,
[292].
,
1200 ,
. ,
4,3
, ,
(54 39,7% ) [293]. ,
,
.
.
[294],
11 712 121 829 (52 , ).
, 23 ,
()
[295], 20 032 75 561
26 669 .
.
,
,
.
[41, 293],
.
. ,
[296299] (
), 1998 .
Joint United Network for Organ Sharing (
)
2
[298].
1 <35% , 2 7,38,0
(5560 . .) , 2 >6,7 (50 . .)
[300, 301].
,
.
, ,
(Candida,
Aspergillus, Cryptococcus, Carini)
(Pseudomonas, Staphylococcus) ,
[297].
.
, ,
110 000 200 000 .
(
)
[302305],
.
.
, ;
,
,
.
,
, , .
,
, /
[306311].
,
, ;
2,74,7 [306].
:
.
;
.
,
, ; .
,
,
.
,
71
, ,
, ,
(
), ,
, .
,
,
, .
,
. , ,
1
<2 50% / DL CO <50% ,
[310].
72
,
[311].
,
/
,
, .
.
,
.
,
[311].
4:
,
,
/
,
,
.
,
( ).
(
2
)
( ).
,
(
, ),
(
).
, pH ,
,
PaCO2, ,
,
(
).
,
.
(
) [312316].
,
, /
,
,
[317, 318].
(
[314]) /
[317].
;
,
[319].
. ,
,
10%,
[320].
,
1 40%;
( 49%) 3
[316, 320325]. ,
[140],
[326, 327]
[325]. , ,
,
[328].
[329],
.
,
.
, 50%
[330332]. ,
.
,
[330]
[332].
[333336].
73
, ,
/ ,
.
, ,
, , ,
.
,
/
, .
,
,
[314, 336].
,
, ,
, ,
(. 5
4
1).
,
.
, ,
,
,
, .
,
, ,
.
( IV)
,
.
.
5
4
1. :
1
/
74
.
,
.
.
.
,
. 2 <8
(60 . .) / SaO2 <90% ( 2
, 6,7 , 50 . .),
.
,
(pH 7,36)
(PaCO2 68 ,
4560 . . )
[311, 337].
.
( )
,
.
,
,
.
,
.
, ,
.
,
, , D
,
.
O2 8 (60 . .),
.
,
.
.
(
>55%) .
.
[33].
Streptococcus pneumoniae, Haemophilus
influenzae Moraxella catarrhalis.
,
.
,
() () (, ,
), ,
.
(. ).
1030%
[319, 338].
,
[190]. ,
, ,
,
.
,
,
.
,
,
[339, 340].
,
.
,
,
( ),
,
.
;
[341344].
, . 5
4
1,
;
[190, 311, 345].
/
, 2 (
). ,
. 5
4
1.
( [346])
;
.
,
.
()
.
,
[347]
[348].
, ,
.
.
.
, (1)
(PaO2) [349352] (
),
,
[353].
1 <50% .
75
5
4
2.
*
,
(, ,
)
* .
5
4
3.
*
( , , )
(PaO2 <5,3 ,
40 . .), / / (PaCO2 >8 ,
60 . .), / /
(pH <7,25),
* .
5
4
4. ,
[346]*
, ,
3060
:
/
2
,
:
(,
, )
* .
, ,
, , ,
.
,
[320].
,
.
[354];
,
, ,
,
[355]*.
[356]
,
.
.
. 5
4
2
.
()
(. 5
4
3).
,
,
.
,
,
,
(. . 5
4
3).
,
.
, . 5
4
4.
.
.
* , .
,
, 12 24
.
.
. . .
.
, .. 2 >8 (60 . .) SaO2
>90%, ,
O2
.
3060
,
O2 (
). (
)
,
[311].
.
2
[190, 311, 357] ( ).
,
, ,
.
,
.
(
)
[358362] (
B).
,
;
[363, 364].
,
(2
)
.
.
[350, 351] (
). ,
, ,
.
30 40 710
( C).
(, , ).
.
,
,
[365];
5
4
5.
,
,
[177, 311]*
H. influenzae
S. pneumoniae
M. catarrhalis
Chlamydia pneumoniae
()
(
,
S. pneumoniae),
(K. pneumoniae,
E. coli, Proteus,
Enterobacter ..)
P. aeruginosa
P. aeruginosa
*
: , ,
(>3 ),
3 [177, 311, 372].
,
, [314].
.
[11];
,
,
(
).
.
,
,
,
[366].
[62, 311],
:
,
,
( B);
77
5
4
6.
a, b [177, 311, 332]
()
:
(,
/
d)
/
/
()
Pseudomonas:
e
(,
f)
()
()
/
()
(,
,
e)
2 3
()
/
e
(,
(,
,
/
)
)
2 3
e
(,
)
e
(,
f)
P. aeruginosa
.
.
.
b. (
).
S. pneumoniae
(. . 545 , , ).
c. : , .
d.
H. influenzae, M. catarrhalis / S. pneumoniae.
e. .
f. 750 P. aeruginosa.
,
,
( C);
,
( B).
78
[177, 367].
H. influenzae, S. pneumoniae M. catarrhalis
[177, 330, 331, 368].
,
Mycoplasma pneumoniae Chlamydia pneumoniae [368,
369];
.
,
,
[370, 371], ,
P. aeruginosa.
,
[372,
373].
S. pneumoniae.
1
,
H. influenzae M. catarrhalis,
,
P. aeruginosa (. 5
4
5) [177, 311].
P. aeruginosa
,
(4 ),
P. aeruginosa
[372, 373].
. 5
4
6 [177, 311, 332]
, ;
,
, ,
.
( )
.
;
.
[374376],
37 (
D).
[357].
,
,
,
[377].
.
, .
()
, ,
, ()
.
,
8085% [285,
378380]. ,
(
O2), ,
,
( ).
, ( ,
)
[380383].
(. 5
4
7) [285].
.
,
, ,
,
,
[387, 388].
. 5
4
8; ,
[389].
,
. . 5
4
9
,
.
,
.
,
(. . 58).
(
), ,
.
,
,
,
[324].
1749% [316].
5
4
7.
[311, 378, 384, 385]
(pH 7,35) / (PaCO2 >6 ,
45 . .) [386]
>25
( )
(, , )
;
5
4
8.
(
, . . 5
4
7)
>35
(pH <7,25) / (PaCO2 >8 , 60 . .)
,
(, )
( , ,
, , ,
)
5
4
9. ,
( )
,
12 ,
,
(1 <30% ),
. ,
,
(
)
,
.
(
)
79
5
4
10.
2 4
1224
1224
( , )
(,
, )
, ,
5
4
11.
46
1
/
( IV )
.
,
,
[390].
[391393].
, (
) [394396].
, [89, 92].
,
, ,
[397].
.
:
(
); (, );
(
, ..) ,
,
;
(
,
). , 25
,
80
.
N
, .
,
.
[312, 398, 399].
,
,
. 5
4
10. . 5
4
11 ,
4
6 .
,
,
[355].
[190, 400402].
3
/ .
,
.
:
,
(
),
( [32, 403, 404]) ,
.
,
: ,
, .
3
[405].
,
,
, .
1. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung
disease and markers of inflammation: data from the Third National
Health and Nutrition Examination. Am J Med 2003;114(9):75862.
81
82
83
84
85
86
87
88
89
90
91
6:
,
.
.
,
.
;
.
.
.
15
,
,
.
( )
,
.
,
.
,
,
.
,
GOLD.
, ,
, .
,
,
,
/
,
,
.
.
,
.
.
(, , )
.
,
,
,
.
,
;
/
.
,
.
(British
Medical Research Council, MRC) [1],
,
(Clinical COPD Questionnaire, CCQ) [2],
,
,
( IPAG, International Primary Care Airways
Group),
(http://www.ipag.org).
93
,
.
,
.
[3, 4]
.
,
,
[5].
.
,
[6].
,
,
[68]. ,
.
,
.
,
.
,
(
) .
,
,
.
.
. , 25%
65
(
), 10%
. 75
40 25% [9].
,
94
.
[10].
:
, ,
.
): ,
,
.
;
.
, :
.
,
, ,
, ,
.
.
:
,
. ,
,
.
,
,
,
.
.
,
,
.
; ,
.
;
,
. ,
.
GOLD
GOLD
GOLD,
,
.
GOLD,
,
,
(http://www.goldcopd.org/WCDIndex.asp).
GOLD,
,
, ,
.
(WONCA, World
Organization of Family Doctors).
.
GOLD
(GARD, Global Alliance Against Chronic Respiratory
Diseases);
2006 .
,
.
GARD
(http://www.who.int/respiratory/gard/en/).
,
,
.
,
,
, ,
.
:
[11].
1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW,
Wedzicha JA. Usefulness of the Medical Research Council (MRC)
dyspnoea scale as a measure of disability in patients with chronic
obstructive pulmonary disease. Thorax 1999;54(7):5816.
2. Van Der Molen T, Willemse BW, Schokker S, Ten Hacken NH,
Postma DS, Juniper EF. Development, validity and responsive
ness of the Clinical COPD Questionnaire. Health Qual Life
Outcomes 2003;1(1):13.
3. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH.
Spirometry in primary care practice: the importance of quality
assurance and the impact of spirometry workshops. Chest
1999;116(2):41623.
4. Schermer TR, Jacobs JE, Chavannes NH, Hartman J,
Folgering HT, Bottema BJ, et al. Validity of spirometric testing
in a general practice population of patients with chronic obstruc
tive pulmonary disease (COPD). Thorax 2003;58(10):8616.
5. Schermer T, Eaton T, Pauwels R, van Weel C. Spirometry in pri
mary care: is it good enough to face demands like World COPD
Day? Eur Respir J 2003;22(5):7257.
6. Bolton CE, Ionescu AA, Edwards PH, Faulkner TA, Edwards SM,
Shale DJ. Attaining a correct diagnosis of COPD in general
practice. Respir Med 2005;99(4):493500.
7. Caramori G, Bettoncelli G, Tosatto R, Arpinelli F, Visona G,
Invernizzi G, et al. Underuse of spirometry by general practition
ers for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis
2005;63(1):612.
8. Walters JA, Hansen E, Mudge P, Johns DP, Walters EH,
WoodBaker R. Barriers to the use of spirometry in general
practice. Aust Fam Physician 2005;34(3):2013.
9. van Weel C. Chronic diseases in general practice: the longitudinal
dimension. Eur J Gen Pract 1996;2:1721.
10. Schellevis FG, Van de Lisdonk EH, Van der Velden J,
Hoogbergen SH, Van Eijk JT, Van Weel C. Consultation rates
and incidence of intercurrent morbidity among patients
with chronic disease in general practice. Br J Gen Pract
1994;44(383):25962.
11. Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P.
A chronic disease management programme can reduce days in
hospital for patients with chronic obstructive pulmonary disease.
Intern Med J 2004;34(11):60814.
95
,
2006 .
..
,
@ http://www.goldcopd.org
..
..
..
,
127473 . , . , . 11, . 1
./: (499) 9731416
05.09.2007 .
60 90 1/8
. . 12
10 000
2332
105005 , . , 46
This translation and printing of this document in Russian was made possible
through an unrestricted educational grant from Boehringer Ingelheim
,
2006 .
Visit the GOLD Website at www.goldcopd.org